Purity:SDS-PAGE

Anti-LIV-1 / SLC39A6 Reference Antibody (ladiratuzumAb) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

Purity:SEC-HPLC

The purity of Anti-LIV-1 / SLC39A6 Reference Antibody (ladiratuzumAb) is 98.2%, determined by SEC-HPLC.

Bioactivity:ELISA

Immobilized human LIV 1 His at 2 ug/mL can bind Anti-LIV-1 / SLC39A6 Reference Antibody (ladiratuzumAb), EC50=0.005145 ug/mL.

FACS

Human LIV1 HEK293 cells were stained with Anti-LIV-1 / SLC39A6 Reference Antibody ((ladiratuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC220=0.06904 ug/mL.

-25~-15℃保存，有效期1年。